Reduction in Use of Risperidone for Dementia in Australia Following Changed Guidelines

Reduction in Use of Risperidone for Dementia in Australia Following Changed Guidelines

<b>Background:</b> Risperidone is the only antipsychotic approved in Australia for the management of the behavioural and psychological symptoms of dementia (BPSD). In June 2015, the Australian Government Therapeutic Goods Administration (TGA) amended the indication to restrict use in BPS...

Full description

Bibliographic Details
Main Authors: Lisa M Kalisch Ellett, Anna K Moffat, Svetla Gadzhanova, Nicole L Pratt, Jemisha Apajee, Michael Woodward, Elizabeth E Roughead
Format: Article
Language:English
Published: MDPI AG 2019-07-01
Series:Pharmacy
Subjects:
behavioural and psychological symptoms of dementia (BPSD)
risperidone
antipsychotics
medication use restrictions
potentially inappropriate medicines
older people
Online Access:https://www.mdpi.com/2226-4787/7/3/100

Internet

https://www.mdpi.com/2226-4787/7/3/100

Similar Items